First patient recruited in Lyon (F)!
We are happy to announce that the CHU de Lyon in France enrolled the first study participant on 14th of June 2024. Congratulation to the study team!
We are happy to announce that the CHU de Lyon in France enrolled the first study participant on 14th of June 2024. Congratulation to the study team!
We are happy to annouce that 3 additional sites beside CHU Brest could be initiated in April and May 2024. We wish the study teams at all four sites good luck for recruiting of trial participants!
We wish the study team good luck!
We are happy to announce that the Ottawa Hospital in Canada enrolled the first study participant on 8th of November 2023. Congratulation to the study team!
We are happy to inform you that the first site in France, the Hôpital de la Cavale Blanche (CHU) is open for accrual since Agust 30 2023. We wish the study team in Brest good luck for patient enrollment!
We are pleased to inform you that the first trial participant was enrolled at the Cantonal Hospital in Liestal (CH) on 17th of June 2023. Thank you for your great effort!
We are happy to inform you that the fifth Dutch site, Medisch Spectrum Twente in Enschede, could be opened for patient recruitment. We wish the study team good luck!
We are happy to inform you that the fifth Dutch site, the Haaglanden Medisch Centrum in Den Haag, could be opened for patient recruitment on 1st of February 2023. We wish the study team good luck!
We are pleased to inform you that the first trial participant was enrolled at the Hospital of Neuchâtel on 22nd of December 2022. Thank you for your great effort!
We are pleased to inform you that the first trial participant was enrolled at the Isala Klinieken in Zwolle (NL) on 29th of November 2022. Thank you for your great effort!
Prof. Dr. med. Drahomir Aujesky
Klinikdirektor und Chefarzt Allgemeine Innere Medizin
Universitätsspital Inselspital
safe-sspe@insel.ch